Jim Cramer Highlighted 21 Stocks, Including Dow and Home Depot

In this article, we will look at Jim Cramer’s latest stock calls, as he suggested investors balance portfolios with hot and cold stocks. The host of Mad Money said Thursday that investors should stop chasing only the market’s hottest trades and instead pay attention to areas that have fallen out of favor, specifically healthcare stocks.

We know that certain parts of this market are as hot as a just-fired pistol. Tonight, though, I want to praise the other parts of the market, the parts that have been marked down already, which makes them less vulnerable to surprises. And I’m talking about healthcare, a group that used to represent safety, always has some growth, but is now considered poison… I like value, especially when it’s attached to a growth industry like healthcare.

READ ALSO Jim Cramer’s Mad Money Recap: 12 Stocks, Including RTX & Marvell and Jim Cramer’s 17 Stock Calls: Applied Materials and CoreWeave

Questioning how investors can shield portfolios from sharp downturns, Cramer suggested that rather than chasing momentum, investors should buy stocks that have already taken significant hits, describing them as “pulverized” and heavily sold off despite representing strong underlying businesses. He said that healthcare fits the description and offers an opportunity for those willing to look past current sentiment.

Bottom line: I think these quality healthcare names help to balance out your portfolio right now, giving you something that can’t be savaged by AI displacement that I can tell. Good balance, something tells me you’re going to need it.

Our Methodology

For this article, we compiled a list of 21 stocks that were discussed by Jim Cramer during the episode of Mad Money aired on April 23. We listed the stocks in the order that Cramer mentioned them.

Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 498.7% since May 2014, beating its benchmark by 303 percentage points (see more details here).

Jim Cramer Highlighted 21 Stocks, Including Dow and Home Depot

21. POET Technologies Inc. (NASDAQ:POET)

POET Technologies Inc. (NASDAQ:POET) was among Jim Cramer’s latest stock calls, as he suggested investors balance portfolios with hot and cold stocks. Noting the stock’s parabolic move, Cramer said:

Then there’s POET, Navitas, and Credo. These are all semiconductor networking stocks that have gone parabolic, each up around 100% this month. We profiled POET earlier this week. Sounds interesting, but not 100% up interesting. Sell some. If you’re sitting on one of these thinking that you’ve made money, no, you haven’t. You don’t make money until you ring the register.

POET Technologies Inc. (NASDAQ:POET) manufactures semiconductor products using an optical interposer platform that integrates electronic and photonic devices onto a single chip. The company develops optical engines and circuits for several industries, including data centers, telecommunications, and AI applications. On April 21, discussing the company in detail, Cramer said:

While I like the story here so far, let’s not get ahead of ourselves with these recent announcements. POET’s got a joint development agreement. They’re not producing this stuff at scale. I’m calling it early. The stock’s trading like they’re already in mass production, and that bothers me. Just look at the numbers. POET’s financials make it look more of a science project than a business… With a company like this, the challenge is never just whether the technology works in a lab demo. You gotta figure out if it can be manufactured consistently and shipped at what we call scale…

So where do I come down? Look, I like the theme a lot. You know that. The scramble to secure lasers, transceivers, optical integration technology, it’s all, it’s happening. POET has a more interesting story than the average speculative small-cap tech name, but I’m not ready to recommend chasing here. If you want to play the theme, I’d still rather you own the more proven companies like Lumentum, like Coherent, both of which have NVIDIA’s endorsement and money. So the bottom line: While I can endorse speculating on POET Technologies, given how much the stock has run, it has a lot of potential, and it’s definitely worth watching. If you really like it, though, I’m begging you to wait for a pullback before you pull the trigger, as I don’t think you can consider yourself to be early to the story. And that’s sometimes what matters the most.

20. Lightwave Logic, Inc. (NASDAQ:LWLG)

Lightwave Logic, Inc. (NASDAQ:LWLG) was among Jim Cramer’s latest stock calls, as he suggested investors balance portfolios with hot and cold stocks. Cramer mentioned that the company has “almost no revenues” and said:

We get a lot of calls about stocks that have gone parabolic here. The other day, I got a call about Lightwave Logic. It develops polymers for networking equipment. Everybody does that these days. Stock’s gone from $4 to $13 in just over six weeks. This company has almost no revenues. It’s up over 93% this month. Perfect candidate for selling half your stock tomorrow morning.

Lightwave Logic, Inc. (NASDAQ:LWLG) develops and licenses advanced polymer materials used to improve data speeds in hardware for artificial intelligence, cloud computing, and telecommunications. It is worth noting that Cramer made similarly bearish comments on the company on April 13, as he said:

It’s hard for me to recommend this as a nearly $2 billion company when it’s losing money, making a hundred thousand bucks in revenue, even if the story’s real and just beginning to get etched into the AI supply chain. That’s why I’d rather stick with Coherent or Lumentum, although you missed a nice part of the run there… Putting the other options aside, though, there are real challenges for Lightwave. I won’t pretend to be an expert in photonics, but we don’t really know if the company’s proprietary material stays stable over time or if it could be manufactured consistently…

I like the theme a lot. I think the market’s right that optics will matter more as AI infrastructure scales up. I think the scramble to secure lasers, transceivers, and photonics components is real. I also think there’s a serious long-term opportunity for somebody that can help deliver higher speed and lower power to the data center at a reasonable cost. And that’s why Lightwave keeps getting attention. The problem is this: This stock has already run as if the future’s settled…. run like Marvell Technology, another great winner in this sector, and I’m not sure that’s the case. See, even though this is one of the hottest and most important themes in the market, I have a hard time telling a conservative investor to chase Lightwave here.

This is the kind of name that can absolutely keep ripping. I get that. This theme isn’t going away anytime soon, I get that. It’s part of the fourth industrial revolution, I get that too. But when a stock is going up tenfold in a year, and the business is still at an incredibly early stage, and losing money with very little revenue, I think some disciplines should matter. You don’t have to hate the technology to say that the stock may have gotten ahead of itself. We don’t even know how difficult it is to mass-produce this product. So here’s the bottom line: If you like what you’ve heard about Lightwave launch, again, look, I gave you some stuff to like, keep it on the watch list, I think. But after such an incredible move, I think there are better, cheaper ways to play this, Coherent, Lumentum, and especially NVIDIA tomorrow morning.

19. Avis Budget Group, Inc. (NASDAQ:CAR)

Avis Budget Group, Inc. (NASDAQ:CAR) was among Jim Cramer’s latest stock calls, as he suggested investors balance portfolios with hot and cold stocks. Urging investors not to buy parabolas, Cramer said:

Next up, the other day, David Faber pointed out that Avis, the rental car company, has seen its stock soar from $100 to $700 in less than a month. Avis happened to be way over shorted at the lows, with many more shares sold short than actually existed. That’s a recipe for the mother of all short squeezes, and we got it.

But how about the longs? Did they do anything? If they didn’t sell Avis into strength, well, they’re fools. After peaking at about $800 a couple of days ago, the stock’s now plunged to $229, and many who bought it in the parabola a few days ago have been wiped out. That’s why you need to be disciplined and sell these things while they’re still on fire. Don’t buy the parabola.

Avis Budget Group, Inc. (NASDAQ:CAR) provides car and truck rentals, car sharing, and related services through brands such as Avis and Zipcar, as well as several other rental brands. The company offers its services to both business and leisure customers.

18. Mega Fortune Company Limited (NASDAQ:MGRT)

Mega Fortune Company Limited (NASDAQ:MGRT) was among Jim Cramer’s latest stock calls, as he suggested investors balance portfolios with hot and cold stocks. Cramer suggested investors take profits in stocks like MGRT as he explained:

You need to be able to recognize when you’re flying too close to the sun. Today, I looked at a list of stocks that have rallied more than 50% this month… And in almost every case, their charts had formed a parabola. What’s a parabola?… This is when a stock goes practically straight up, no breaks. If you have a parabolic move on your hands in one of your stocks, you need to take profits because parabolas quite often lead to crashes…

Let’s say, for example, you bought Mega Fortune Co, which is up over 2,000% this month… Mega Fortune is a Hong Kong-based internet of things solutions provider, whatever… that is. It’s not a lottery ticket even as it sure trades like one… Mega Fortune, a nearly $2 billion company, has $11 million in revenue. It’s become a modern-day meme stock. It was at $6 and change at the end of March. Now, it’s at $140. Look, parabolic moves like this are unsustainable. You simply have to take some profits or else.

Mega Fortune Company Limited (NASDAQ:MGRT) delivers Internet of Things solutions and services, including consulting, development, implementation, and analytics. The company also provides maintenance and support, business process outsourcing, technical consulting services, and trades in hardware and IoT-related products.

17. Insulet Corporation (NASDAQ:PODD)

Insulet Corporation (NASDAQ:PODD) was among Jim Cramer’s latest stock calls, as he suggested investors balance portfolios with hot and cold stocks. Toward the end of the lightning round, a caller sought Cramer’s opinion of the stock, and he said:

Insulet is the stock in the healthcare group. It is the biggest decline of any stock in the healthcare group, and I looked at it today to see if I could recommend it. It’s still too expensive because of the GLP-1 threat, existential.

Insulet Corporation (NASDAQ:PODD) develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers the Omnipod platform, including the Omnipod 5 automated insulin delivery system and Omnipod DASH, along with the broader Omnipod Insulin Management System. Parnassus Investments stated the following regarding Insulet Corporation (NASDAQ:PODD) in its third quarter 2025 investor letter:

Insulet Corporation (NASDAQ:PODD) is the sole manufacturer of a tubeless insulin pump to treat diabetes. The company has durable competitive advantages from its intellectual property and proprietary production processes. Insulet’s addressable market has the potential to significantly increase if it expands from Type 1 diabetics to the larger population of Type 2 diabetics.

16. Rivian Automotive, Inc. (NASDAQ:RIVN)

Rivian Automotive, Inc. (NASDAQ:RIVN) was among Jim Cramer’s latest stock calls, as he suggested investors balance portfolios with hot and cold stocks. A caller asked if Cramer is “warming up to it,” and he replied:

That last quarter was good. I was surprised… It looks like they’re going to make it, and if they’re going to make it, then the stock goes higher. By the way, I’m going to give you a twofer, I like Tesla today. Okay, those who don’t like Tesla, they can come see me, and…. Those are the same people who’ll probably short Intel.

Rivian Automotive, Inc. (NASDAQ:RIVN) manufactures electric vehicles and provides related software, charging, and maintenance services. When a caller asked Cramer about the company on December 22, 2025, he said:

Look, I’m a balance sheet guy. This has had a major, major move. It’s been terrific. I think some of it is a short squeeze. There’s a very big short. I want you to take some off the table and then let the rest run because in the end, I care more about maintaining gains when it comes to the heavily speculative stocks that are losing a lot of money. Let’s take some off the table, rest run.

15. Dave Inc. (NASDAQ:DAVE)

Dave Inc. (NASDAQ:DAVE) was among Jim Cramer’s latest stock calls, as he suggested investors balance portfolios with hot and cold stocks. When a caller mentioned that they have been holding the stock for a while, Cramer remarked:

I like… really packed energy bars more than I like Dave, this kind of pseudo fintech. We are going to sell fintech.

Dave Inc. (NASDAQ:DAVE) offers a financial services platform that includes Budget, a personal money management tool that uses historical bank data to track recurring charges and alert members about upcoming transactions, along with ExtraCash, a discretionary overdraft feature designed to help cover short-term cash gaps between paychecks. The company also provides Side Hustle, a job application portal for finding additional or temporary work, and Dave Checking, a digital demand deposit account.

On April 10, Citizens increased its price target to $335 from $310 and maintained an Outperform rating on the shares. The adjustment was made within its capital markets and fintech group coverage as part of a first-quarter earnings preview. The analyst said that “navigating volatility remains the central challenge across the sector”. Citizens added that capital market conditions were better in pockets than across the board, with institutional trading described as the clearest bright spot of the quarter. The firm also noted that crypto sentiment “remains impaired” in the near term. But it also noted that the market is placing too much focus on the current slowdown in activity and not enough attention on medium-term policy and business catalysts.

14. SoundHound AI, Inc. (NASDAQ:SOUN)

SoundHound AI, Inc. (NASDAQ:SOUN) was among Jim Cramer’s latest stock calls, as he suggested investors balance portfolios with hot and cold stocks. A caller asked about Cramer’s thoughts on the stock, and he said, “No, no, no, we don’t want to be in… We cannot be in SoundHound. We’re better than that.”

SoundHound AI, Inc. (NASDAQ:SOUN) develops voice AI technologies that enable businesses to create conversational and intelligent voice experiences. It should be noted that Cramer expressed a bearish sentiment toward the company when a caller inquired about it on April 10, as he commented:

See, I don’t know, still made no… money. And it was, look, there was a bit of time at one point when NVIDIA had a position in, and everyone got all excited about it. And you know, now I just think make some money, and I’ll talk about you, but they ain’t making money. So I’m a no go on that one, partner.

13. Critical Metals Corp. (NASDAQ:CRML)

Critical Metals Corp. (NASDAQ:CRML) was among Jim Cramer’s latest stock calls, as he suggested investors balance portfolios with hot and cold stocks. Answering a caller’s query during the lightning round, Cramer said:

No, look, it’s a spec, and I get that. But if you really want to be in that industry, you have to buy MP Materials. They’re for real.

Critical Metals Corp. (NASDAQ:CRML) is a mining exploration and development company focused on lithium and rare earth element deposits in Austria and Southern Greenland. On October 16, 2025, responding to a caller, Cramer said:

We’ve talked about this, Ben Stoto and I. It is time to kaching kaching Critical Metals. You need President Trump to go in there and buy 10% of the company. I don’t think it’s going to happen.

12. PG&E Corporation (NYSE:PCG)

PG&E Corporation (NYSE:PCG) was among Jim Cramer’s latest stock calls, as he suggested investors balance portfolios with hot and cold stocks. Discussing the company’s recently reported quarterly results, Cramer said:

It is a great time to be an electric utility, thanks to the surging power demand from all these new data centers. But some of the utilities are not getting the respect… Some of these great growth utilities are around the country. We got to figure this thing out. Take PG&E, which is based in Northern and Central California. This morning, the company reported a sizable top and bottom line beat while reaffirming its full-year forecast and also reiterating its long-term earnings growth targets, 9% annual growth from 2027 to 2030. At the same time, they’ve been laying down lots of infrastructure to keep residential electric rates under control… I think PG&E is a great growth story, but the stock market doesn’t seem to agree with me, as the stock actually got dinged today on these numbers.

PG&E Corporation (NYSE:PCG) provides electricity and natural gas, generating power from nuclear, hydroelectric, fossil-fuel, fuel-cell, and solar sources. Moreover, the company owns and operates extensive transmission and distribution infrastructure for both electricity and natural gas.

11. Thermo Fisher Scientific Inc. (NYSE:TMO)

Thermo Fisher Scientific Inc. (NYSE:TMO) was among Jim Cramer’s latest stock calls, as he suggested investors balance portfolios with hot and cold stocks. Noting the market’s reaction to the company’s recently reported quarter, Cramer said:

Alright, what just happened to the stock of Thermo Fisher Scientific, the arms dealer to the life sciences industry that I’ve liked for so long? This morning, Thermo Fisher reported what looks like a very solid set of numbers, a modest revenue beat paired with a healthy 19-cent earnings beat off a $5.25 basis. Management also raised their full-year forecast substantially, but their guidance for the current quarter came in light. In response, the stock got obliterated today, plunging $47.28 or 9.2% to the point where the stock’s now down nearly 20%… I think that the market has this wrong… This is a great American company.

Thermo Fisher Scientific Inc. (NYSE:TMO) provides instruments, reagents, consumables, software, and lab services that support scientific research, diagnostics, and drug and vaccine development.

10. Dow Inc. (NYSE:DOW)

Dow Inc. (NYSE:DOW) was among Jim Cramer’s latest stock calls, as he suggested investors balance portfolios with hot and cold stocks. Cramer noted that the stock declined even after reporting a good quarter because it was already up significantly for the year.

When Iran shut down the Strait of Hormuz, that was terrible for the global economy. We all know that, right? But it’s also great for the price of oil and the price of petrochemicals, for that matter. This has been tremendous for American chemical companies to get all the supplies they need domestically. And that’s why Dow, the big chemical company, has gone from being the sixth worst performer in the S&P 500 last year to one of the top 20 this year, up nearly 65% for 2026.

What have they done for me lately? How about go up? Now, this morning, Dow reported a solid quarter, a healthy revenue beat paired with a smaller-than-expected loss. Even though this company doesn’t give formal guidance, management’s conference call commentary, I thought, was very upbeat. Unfortunately, maybe for today, it wasn’t enough. The stock slipped 7% because I think when you’re up nearly 65% for the year, that means expectations went skyward.

Dow Inc. (NYSE:DOW) develops chemical and material products used in packaging, construction, transportation, and consumer industries.

9. The Home Depot, Inc. (NYSE:HD)

The Home Depot, Inc. (NYSE:HD) was among Jim Cramer’s latest stock calls, as he suggested investors balance portfolios with hot and cold stocks. When a caller asked about the stock, Cramer said:

When I did the Home Depot work for the Trust, Home Depot is a, it’s a template, okay? It’s an example. It’s an analog. Home Depot is what you buy when you get rate cuts. It is time-honored… This is the stock you own when you get rate cuts. You don’t buy Intel when you get rate cuts, although you should buy Intel. I can’t believe I’ve been saying good things about Intel. I never told people, just buy Intel.

The Home Depot, Inc. (NYSE:HD) is a home improvement retailer that sells tools, building materials, and decor. Furthermore, the company provides installation and equipment rental services. Carillon Tower Advisers stated the following regarding The Home Depot, Inc. (NYSE:HD) in its fourth quarter 2025 investor letter:

The Home Depot, Inc. (NYSE:HD) traded lower after reporting weaker‑than-expected same‑store sales for the prior quarter. While weather‑related events boosted results in the prior quarter, the additional demand management anticipated failed to materialize. On a positive note, recent acquisitions continue to perform well and appear likely to be a tailwind as the business environment improves.

8. UnitedHealth Group Incorporated (NYSE:UNH)

UnitedHealth Group Incorporated (NYSE:UNH) was among Jim Cramer’s latest stock calls, as he suggested investors balance portfolios with hot and cold stocks. Cramer mentioned that despite the company reporting the “best managed care earnings I’ve seen in ages,” its stock still went down.

Okay, finally, we’re going to get to the one that you’re going to buy tomorrow, alright, UnitedHealth Group. Here’s a company that just reported its first solid beat and raise quarter in a very long time. Returning CEO, Steve Hemsley, who turned UNH into a juggernaut before he retired in 2017, is back, and he is doing the same thing he did for years the last time he was CEO. Produced the best earnings and biggest upside surprises in the real. They’re not chimerical. They’re not made up. They’re none of that jack stuff.

Yet after all of that, after putting up the best managed care earnings I’ve seen in ages, stock still sells for just 19 times earnings. Boy, this group is hated. The man is just getting started. The stock deserves to be much higher. Okay, here’s a little clue. UNH, we’ll do a little cinéma-vérité here… The UNH is at $354. This stock was at $600 last April, April of 2025. You know why I like these stocks so much? Because if they come down further, you can just keep buying them hand over fist. Because you know what? When they go down, they actually get cheaper.

UnitedHealth Group Incorporated (NYSE:UNH) provides health care services, insurance plans, pharmacy care, and data-driven solutions.

7. Johnson & Johnson (NYSE:JNJ)

Johnson & Johnson (NYSE:JNJ) was among Jim Cramer’s latest stock calls, as he suggested investors balance portfolios with hot and cold stocks. Cramer noted that the stock has been “doing nothing,” as he said:

Or how about a stock I talked about earlier in the week that’s doing nothing, JNJ. Johnson & Johnson, AAA balance sheet, one of only two. The other being Microsoft. J&J has the best pipeline of potential blockbusters of any pharmaceutical company, yet it sells at a little less than 20 times earnings. These are just, these are discounts.

Johnson & Johnson (NYSE:JNJ) develops and sells healthcare products, including pharmaceuticals and medical technologies, with treatments in immunology, oncology, neuroscience, cardiovascular care, and infectious diseases. On April 20, Cramer expressed his bullish sentiment toward the company and the stock as he stated:

We bought the stock of Johnson & Johnson today for the Charitable Trust… Are we crazy? No, we’re not crazy. We’re buying what may be the best drug stock, or at least the second-best if you’re Eli Lilly. We’re buying it into free fall. You don’t get a chance to buy the best at a discount very often. When you do, you buy some, then you let it fall a little more, and you buy some more. And we’ll likely get that opportunity because pharma is so out of favor… Why J&J right now? We’ve had a lot of noise in healthcare. It’s obscured a major FDA approval for a new J&J drug, Icotyde, an autoimmune drug for the treatment of moderate to severe psoriasis, which is a gigantic market…

Doesn’t hurt that the company decided to spin off its orthopedics business as a standalone company. This is a slower-growing piece of the pie, so the breakup will help unlock value. In the past, JNJ might have gotten credit for these moves, but right now, buyers have deserted the stock. I like that, too. Always remember, though, that this is the kind of stock that gets cheaper as it goes lower, which is why we’ve left plenty of room to buy more JNJ on weakness for the Charitable Trust. More important, your portfolio always needs to have a decent mix between what’s hot and what’s not… Here’s something I was taught at Goldman Sachs: They don’t all go up at once. To which I always said, but something should go up in your portfolio. And that’s why you buy J&J, one of the greatest drug companies out there, one of the greatest American companies out there, when everyone else is selling it.

6. Cardinal Health, Inc. (NYSE:CAH)

Cardinal Health, Inc. (NYSE:CAH) was among Jim Cramer’s latest stock calls, as he suggested investors balance portfolios with hot and cold stocks. Cramer said that a “vicious rotation out of healthcare” is the reason behind the stock being crushed.

Next, I’m a huge believer in Cardinal Health with a stock that’s just been annihilated here without any reason, other than, I think, a vicious rotation out of healthcare. Cardinal’s down from $233 to $204. It’s beaten the quarterly estimates repeatedly, shifts its model from being a pure middleman to being a drug wholesaler, to being a manager of services to its clients… Given the complexity of large independent medical organizations, Cardinal’s filling a gap in management for specialty chains that really don’t know how to run their own business. I think there’s maybe many more to come. High growth that now trades at less than 20 times earnings. To me, Cardinal’s a steal. Although we’ve been buying it for the Charitable Trust, and admittedly, I started early. Some would say wrong. Okay.

Cardinal Health, Inc. (NYSE:CAH) supplies branded, generic, and specialty medicines and provides pharmacy and specialty drug services. The company also makes and distributes medical and surgical products and procedure kits.

Click to continue reading and see Jim Cramer Highlighted 5 Stocks, Including Meta and Tesla.

Disclosure: None. Follow Insider Monkey on Google News.